Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.
作者信息
Arakeri Gururaj, Patil Shreyas, Rao Us Vishal, Amaral Mendes Rui, Oeppen Rachel S, Brennan Peter A
机构信息
Department of Head and Neck Oncology, Centre for Academic Research, HCG Cancer Center, Bengaluru, Karnataka, India; Department of Oral and Maxillofacial Surgery, Navodaya Dental College and Hospital, Raichur, Karnataka, India.
Department of Medicine, RajaRajeswari Medical College and Hospital, Bengaluru, Karnataka, India.
出版信息
Br J Oral Maxillofac Surg. 2022 May;60(4):e533-e534. doi: 10.1016/j.bjoms.2021.10.018. Epub 2021 Nov 15.
Abstract
摘要
相似文献
1
Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.印度2019冠状病毒病相关毛霉病（CAM）的发病机制：探究触发因素。
Br J Oral Maxillofac Surg. 2022 May;60(4):e533-e534. doi: 10.1016/j.bjoms.2021.10.018. Epub 2021 Nov 15.
2
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
3
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.印度 COVID-19 相关毛霉菌病（CAM）：一个严峻的挑战。
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098. doi: 10.1016/j.bjoms.2021.06.013. Epub 2021 Jun 29.
4
Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.糖尿病、COVID-19 和毛霉菌病：印度西部一家三级护理医疗中心的临床谱和结局。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102196. doi: 10.1016/j.dsx.2021.102196. Epub 2021 Jul 3.
5
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
6
COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors.印度的新冠病毒病与毛霉菌病：相关危险因素研究
J Assoc Physicians India. 2022 May;70(5):11-12.
7
Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.锌与新冠病毒相关毛霉菌病之间存在关联吗？一项实验与临床研究的结果
Mycoses. 2021 Oct;64(10):1291-1297. doi: 10.1111/myc.13365. Epub 2021 Sep 1.
8
Mucormycosis and COVID-19: Double trouble for India?毛霉菌病与新冠疫情：印度的双重麻烦？
J Glob Health. 2022 Feb 12;12:03001. doi: 10.7189/jogh.12.03001. eCollection 2022.
9
COVID-19 associated mucormycosis - An emerging threat.新型冠状病毒肺炎相关毛霉菌病——一种新出现的威胁。
J Microbiol Immunol Infect. 2022 Apr;55(2):183-190. doi: 10.1016/j.jmii.2021.12.007. Epub 2022 Jan 13.
10
Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic.新冠疫情期间印度的毛霉病流行与中风
Stroke. 2021 Oct;52(10):e622-e623. doi: 10.1161/STROKEAHA.121.036626. Epub 2021 Sep 16.
引用本文的文献
1
Intratemporal mucormycosis: a rare COVID-19 sequelae.颞骨毛霉菌病：一种罕见的 COVID-19 后遗症。
BMJ Case Rep. 2023 Apr 12;16(4):e250533. doi: 10.1136/bcr-2022-250533.
2
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.新型冠状病毒肺炎相关毛霉菌病：严重急性呼吸综合征冠状病毒2大流行期间令人担忧的问题
Vaccines (Basel). 2022 Aug 6;10(8):1266. doi: 10.3390/vaccines10081266.
本文引用的文献
1
Additional insights on COVID-associated mucormycosis.关于新冠相关毛霉菌病的更多见解。
Br J Oral Maxillofac Surg. 2022 May;60(4):e531-e532. doi: 10.1016/j.bjoms.2021.09.020. Epub 2021 Nov 15.
2
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.印度 COVID-19 相关毛霉菌病（CAM）：一个严峻的挑战。
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098. doi: 10.1016/j.bjoms.2021.06.013. Epub 2021 Jun 29.
3
Covid-19: India sees record deaths as "black fungus" spreads fear.新冠疫情：随着“黑真菌”引发恐慌，印度死亡人数创历史新高。
BMJ. 2021 May 13;373:n1238. doi: 10.1136/bmj.n1238.
Zotero 插件